BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32364535)

  • 1. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.
    Xing M; Ooi WF; Tan J; Qamra A; Lee PH; Li Z; Xu C; Padmanabhan N; Lim JQ; Guo YA; Yao X; Amit M; Ng LM; Sheng T; Wang J; Huang KK; Anene-Nzelu CG; Ho SWT; Ray M; Ma L; Fazzi G; Lim KJ; Wijaya GC; Zhang S; Nandi T; Yan T; Chang MM; Das K; Isa ZFA; Wu J; Poon PSY; Lam YN; Lin JS; Tay ST; Lee MH; Tan ALK; Ong X; White K; Rozen SG; Beer M; Foo RSY; Grabsch HI; Skanderup AJ; Li S; Teh BT; Tan P
    J Clin Invest; 2020 Jun; 130(6):3005-3020. PubMed ID: 32364535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
    Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
    J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.
    Rajagopalan D; Pandey AK; Xiuzhen MC; Lee KK; Hora S; Zhang Y; Chua BH; Kwok HS; Bhatia SS; Deng LW; Tenen DG; Kappei D; Jha S
    PLoS Pathog; 2017 Oct; 13(10):e1006681. PubMed ID: 29045464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.
    Suryo Rahmanto Y; Jung JG; Wu RC; Kobayashi Y; Heaphy CM; Meeker AK; Wang TL; Shih IeM
    J Biol Chem; 2016 Apr; 291(18):9690-9. PubMed ID: 26953344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
    Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
    Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
    McKelvey BA; Umbricht CB; Zeiger MA
    Front Endocrinol (Lausanne); 2020; 11():485. PubMed ID: 32849278
    [No Abstract]   [Full Text] [Related]  

  • 7. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
    Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
    Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer.
    Lee DD; Komosa M; Sudhaman S; Leão R; Zhang CH; Apolonio JD; Hermanns T; Wild PJ; Klocker H; Nassiri F; Zadeh G; Diplas BH; Yan H; Gallinger S; Pugh TJ; Ramaswamy V; Taylor MD; Castelo-Branco P; Nunes NM; Tabori U
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
    Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
    Akıncılar SC; Khattar E; Boon PL; Unal B; Fullwood MJ; Tergaonkar V
    Cancer Discov; 2016 Nov; 6(11):1276-1291. PubMed ID: 27650951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of telomerase in cancer.
    Akincilar SC; Unal B; Tergaonkar V
    Cell Mol Life Sci; 2016 Apr; 73(8):1659-70. PubMed ID: 26846696
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
    Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
    Kim YJ; Yoo JE; Jeon Y; Chong JU; Choi GH; Song DG; Jung SH; Oh BK; Park YN
    Int J Cancer; 2018 Dec; 143(12):3155-3168. PubMed ID: 29987895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
    Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
    Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
    Ko E; Seo HW; Jung ES; Kim BH; Jung G
    Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
    Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
    Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.